AzTrials
AzTrials

AphasiaNCT05471570

Effect of Anodal Transcranial Direct Current Stimulation (tDCS) Over the Right-hemisphere on Picture Naming in Chronic Aphasia

A study testing tDCS stimulation in people with Aphasia, run by The University of Hong Kong.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

There are two opposing hypotheses, namely the interference and laterality-shift hypotheses, regarding the role of the right hemisphere (RH) in language recovery following a left hemisphere damage. Read more about this study

Who is it for?
Ages 40 to 90 years
Conditions the study is for
Aphasia
What is being tested?
tDCS stimulation
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
4 participants
Where
No sites listed yet
Study dates
1 Jan 2017to 20 Dec 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • People with chronic aphasia following the stroke

Who cannot join

  • history of seizure or epilepsy,
  • previous adverse reactions to TMS/tDCS,
  • having a pace-maker or a metal implanted in the brain
  • being pregnant

About this study

Official title: The Effect of tDCS Stimulation of Right Inferior Frontal Gyrus on Language Recovery in Speakers With Aphasia

There are two opposing hypotheses, namely the interference and laterality-shift hypotheses, regarding the role of the right hemisphere (RH) in language recovery following a left hemisphere damage. Transcranial direct current stimulation (tDCS) has received increasing attention as a potential complement to behavioural therapy.

This preliminary study aimed to examine the effect of excitatory (anodal) stimulation of right inferior frontal gyrus (IFG) on naming abilities of chronic people with aphasia (PWA) to examine the compensatory versus interference role of RH in language recovery, and to confirm the application of tDCS does not induce adverse effects on other cognitive and language functions.

Conditions
Aphasia
Being tested
tDCS stimulation
Keywords
tDCS, Aphasia, naming
Medical subject headings
Aphasia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • tDCS stimulationDevice

    Also called language therapy

    The study examines the effect of excitatory stimulation of right inferior frontal gyrus (IFG) on naming abilities of people with aphasia (PWA) as compared to sham stimulation to examine the compensatory versus interference role of right hemisphere in language recovery after stroke.

Study groups in NCT05471570
Study groupRoleWhat they receive
anodal tDCSActive comparator20 minutes of one mA anodal High-Definition tDCS (HD-tDCS) over right IFG combined with 40 minutes of naming therapy for five consecutive days in week 1
Receives: Device: tDCS stimulation
sham tDCSSham comparator20-minutes sham HD-tDCS with 40-minutes therapy of naming therapy for five consecutive days in week 1
Receives: Device: tDCS stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Picture naming task

    One hundred and sixty pictures of concrete nouns from the Snodgrass and Vanderwart (1980) picture set (colored version) were utilised to measure the percentage of object naming accuracy. In particular, these pictures were divided into Set A (training targets) and Set B (untrained generalization targets), with eighty stimuli in each set.

    Measured: Immediately after the end of each treatment session and block

Secondary outcomes (2)
  1. language task

    • Overall language skills are measured through the overall aphasia scores provided by the Cantonese version of Western Aphasia Battery (short-form).

    The scale is called Aphasia quotient: Minimum value = 0, maximum value = 100, with higher scores mean a better performance.

    Measured: Immediately after the end of each treatment block

  2. Cognitive task

    The cognitive skills are measured through the subtest scores provided by Oxford Cognitive Screening-Cantonese. The test uses different sub-tests including the Picture naming, Semantics, Orientation, Visual field task, Sentence reading , Calculation, Attention, Praxis, Memory, and Executive tasks. The range of values varies across the subtests. For all subtests except the executive task, the higher scores reflect better performance. For executive tasks the lower scores reflect better performance.

    Measured: Immediately after the end of each treatment block

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jul 2022
  2. Study start1 Jan 2017
  3. Primary completion1 Nov 2017
  4. Study completion20 Dec 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
4 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05471570
Sponsor's protocol ID
tDCSAphasia
Status last verified
Nov 2022
First submitted
18 Jul 2022
Last updated
4 Nov 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing tDCS stimulation in people with Aphasia, run by The University of Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Picture naming task (time frame: Immediately after the end of each treatment session and block). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in